RxSight, Inc.
RXST
$14.00
$0.695.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.90M | 40.21M | 35.31M | 34.89M | 29.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.90M | 40.21M | 35.31M | 34.89M | 29.51M |
| Cost of Revenue | 9.57M | 11.43M | 10.09M | 10.64M | 8.83M |
| Gross Profit | 28.33M | 28.79M | 25.22M | 24.25M | 20.69M |
| SG&A Expenses | 28.64M | 28.22M | 25.63M | 24.32M | 23.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.57M | 48.84M | 44.54M | 43.22M | 40.18M |
| Operating Income | -10.67M | -8.63M | -9.23M | -8.33M | -10.67M |
| Income Before Tax | -8.17M | -5.93M | -6.33M | -6.06M | -9.09M |
| Income Tax Expenses | 18.00K | 12.00K | 13.00K | 16.00K | 9.00K |
| Earnings from Continuing Operations | -8.19M | -5.94M | -6.34M | -6.08M | -9.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.19M | -5.94M | -6.34M | -6.08M | -9.10M |
| EBIT | -10.67M | -8.63M | -9.23M | -8.33M | -10.67M |
| EBITDA | -9.90M | -8.11M | -8.09M | -7.52M | -9.56M |
| EPS Basic | -0.20 | -0.15 | -0.16 | -0.16 | -0.25 |
| Normalized Basic EPS | -0.13 | -0.09 | -0.10 | -0.10 | -0.15 |
| EPS Diluted | -0.20 | -0.15 | -0.16 | -0.16 | -0.25 |
| Normalized Diluted EPS | -0.13 | -0.09 | -0.10 | -0.10 | -0.15 |
| Average Basic Shares Outstanding | 40.51M | 40.36M | 39.79M | 38.46M | 36.84M |
| Average Diluted Shares Outstanding | 40.51M | 40.36M | 39.79M | 38.46M | 36.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |